Results for this period
Interim period (second quarter)1 January 2026–30 June 2026Non-consolidated (standalone)Japanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ thousand).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Research and development expenses of ¥206.764 million were recorded, compared with ¥188.257 million in the same period of the previous year, resulting in an operating loss of ¥471.154 million.
Events and other matters that may raise substantial doubt are disclosed. The company recognizes events and other matters that may raise substantial doubt due to continuing negative operating cash flow, but has determined that no material uncertainty exists because it has secured sufficient funds.
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Non-consolidated (standalone) |
| Period Covered | 1 January 2026–30 June 2026 |
| Operating profit | ¥-471 million |
| Ordinary income | ¥-484 million |
| Profit attributable to owners of the parent | ¥-492 million |
| Net income per share | -¥42.40 |
| Equity ratio | End of the current fiscal period 30.1 / End of previous period 43.1 |
| Total assets | ¥2,567 million |
| Net assets | ¥773 million |
| Cash flows from operating activities | ¥-526,076 thousand |
| Cash flows from investing activities | ¥-39,890 thousand |
| Cash flows from financing activities | ¥138,349 thousand |
| Cash and cash equivalents at end of period | ¥2,364,217 thousand |
| Full-year earnings forecast | Net Sales Not disclosed / Operating profit ¥-1,520 million / Ordinary income ¥-1,550 million / Net income ¥-1,616 million |
| Annual Dividend Forecast | ¥0 → ¥0（0.0%） |
| Impairment loss | ¥7,014 thousand |
| Breakdown of extraordinary income (loss) | Extraordinary income Not disclosed / Extraordinary loss Impairment Losses ¥7,014 thousand |
| Disclosure regarding the going concern assumption | Events and other matters that may raise substantial doubt are disclosed. The company recognizes events and other matters that may raise substantial doubt due to continuing negative operating cash flow, but has determined that no material uncertainty exists because it has secured sufficient funds. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Supplementary financial results materials | Yes |
| Availability of Financial Results Briefing | Yes (audience: Not disclosed) |
| Issued Shares at Period-End | 11,622,600 Shares |
| Treasury Shares at Period-End | 0 Shares |
| Factors Behind Changes in Business Performance | Research and development expenses of ¥206.764 million were recorded, compared with ¥188.257 million in the same period of the previous year, resulting in an operating loss of ¥471.154 million. |
Items this document does not state (12)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company recorded research and development expenses of ¥206.764 million, compared with ¥188.257 million in the same period of the previous year, resulting in an operating loss.